Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/49708
Title: Pharmacogenetic testing for personalisation of statin therapy
Authors: Cerdá Iñesta, Judith
Wirth, Francesca
Mifsud Buhagiar, Luana
Zahra, Graziella
Xuereb, Robert G.
Barbara, Christopher
Serracino-Inglott, Anthony
Keywords: Statins (Cardiovascular agents) -- Research -- Malta
Statins (Cardiovascular agents) -- Side effects
Pharmacogenetics
Personalized medicine
Muscles -- Diseases
Hospital pharmacies
Issue Date: 2019-03
Publisher: University of Malta. Department of Pharmacy
Citation: Cerda Inesta, J., Wirth, F., Mifsud Buhagiar, L., Zahra, G., Xuereb, R. G., Barbara, C., & Serracino-Inglott, A. (2019, March). Pharmacogenetic testing for personalisation of statin therapy. Poster session presented at the 24th Congress of the European Association of Hospital Pharmacists (EAHP), Barcelona, Spain.
Cerdá Iñesta J., Wirth F., Zahra G., et al (2019). 5PSQ-021 Pharmacogenetic testing for personalisation of statin therapy. European Journal of Hospital Pharmacy 2019, 26, A211.
Abstract: A poster presentation regarding pharmacogenetic testing for personalisation of statin therapy. Introduction: The SLCO1B1 protein facilitates the hepatic uptake of simvastatin. The SLCO1B1 c.521T>C genetic polymorphism (rs4149056) decreases the function of SLCO1B1 and is a predictor of simvastatin-induced myopathy. SLCO1B1 pharmacogenetic testing and pharmacist interpretation of test results are a step forward to personalise statin therapy. Aims: • To classify a cohort of cardiac patients on simvastatin according to SLCO1B1 c.521T>C genotype and function • To investigate the correlation of SLCO1B1 genotype and function to myopathy risk.
URI: https://www.um.edu.mt/library/oar/handle/123456789/49708
Appears in Collections:Scholarly Works - FacM&SPha



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.